MedPath

BIO-GABAPENTIN

BIO-GABAPENTIN

Discontinued
DIN Number

02450178

Drug Class

Human

Market Date

Jun 21, 2017

Company
HC

biomed pharma

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02450178
AIG Number0125929002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N02BF01 GABAPENTIN
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

GABAPENTINActive
Strength: 400 MG
Monograph: GABAPENTIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.